文献速递新发突发、热带与寄生虫病

寨卡病毒病发病后12-19个月IgM与中和抗体特征

Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset.
PubMed 文献 · Emerg Infect Dis · 2019-01-01

研究检测62例确诊寨卡病毒病患者发病后12-19个月的血清,发现45例(73%)寨卡病毒IgM仍可检出,12例(19%)为可疑;所有患者均有寨卡病毒中和抗体,但39例(63%)同时有登革病毒中和抗体,其中12例(19%)两者滴度差异<4倍,5例(8%)登革滴度高于寨卡4倍以上。IgM持续检出和中和抗体交叉反应使感染时间判定及黄病毒鉴别困难。

要点

  • 发病后12-19个月仍有73%患者可检出寨卡病毒IgM。
  • 63%患者同时存在登革病毒中和抗体,提示交叉反应常见。
  • IgM持久和交叉反应增加寨卡与其他黄病毒鉴别难度。

核心结论

  • 寨卡病毒IgM在发病后12-19个月仍可检出,且中和抗体与登革病毒交叉反应常见,影响感染时间判断和病原鉴别。

研究设计与样本

  • 对62例确诊寨卡病毒病患者发病后12-19个月采集的血清标本检测寨卡病毒IgM及寨卡病毒和登革病毒中和抗体。

主要发现

  • 62例中45例(73%)寨卡病毒IgM可检出,12例(19%)为可疑结果。
  • 所有患者均有寨卡病毒中和抗体,39例(63%)同时有登革病毒中和抗体。
  • 39例中12例(19%)寨卡与登革中和抗体滴度差异<4倍,5例(8%)登革滴度高于寨卡4倍以上。

临床怎么用

  • 对发病较久的疑似寨卡病例,IgM阳性不能单独用于确定感染时间。
  • 解读寨卡血清学时应同时检测登革病毒中和抗体以识别交叉反应。

局限性

  • 样本量有限(62例),未报告其他黄病毒抗体检测及随访动态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Data on the duration of detectable Zika virus-specific IgM in infected persons are limited. Neutralizing antibody cross-reactivity occurs between Zika virus and related flaviviruses, but the degree to which this confounds diagnosis is uncertain. We tested serum specimens collected 12-19 months after illness onset from patients with confirmed Zika virus disease for Zika virus IgM and Zika virus and dengue virus neutralizing antibodies. Among 62 participants, 45 (73%) had detectable Zika virus IgM and 12 (19%) had an equivocal result. Although all patients tested had Zika virus neutralizing antibodies, 39 (63%) also had neutralizing antibodies against dengue virus; of those, 12 (19%) had <4-fold difference between Zika virus and dengue virus titers, and 5 (8%) had dengue virus titer >4-fold higher than Zika virus titer. Prolonged detection of IgM and neutralizing antibody cross-reactivity make it difficult to determine the timing of Zika virus infection and differentiate between related flaviviruses.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Griffin I, Martin SW, Fischer M, et al. Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset. Emerg Infect Dis. 2019. PMID: 30666931. doi:10.3201/eid2502.181286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。